• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习的经颈静脉肝内门体分流术后肝硬化患者生存预测模型的开发与验证

Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shunt.

作者信息

Da Binlin, Chen Huan, Wu Wei, Guo Wuhua, Zhou Anru, Yin Qin, Gao Jun, Chen Junhui, Xiao Jiangqiang, Wang Lei, Zhang Ming, Zhuge Yuzheng, Zhang Feng

机构信息

Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

Research Institute of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

出版信息

EClinicalMedicine. 2024 Dec 16;79:103001. doi: 10.1016/j.eclinm.2024.103001. eCollection 2025 Jan.

DOI:10.1016/j.eclinm.2024.103001
PMID:39802305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11719861/
Abstract

BACKGROUND

Although numerous prognostic scores have been developed for patients with cirrhosis after Transjugular intrahepatic portosystemic shunt (TIPS) placement over years, an accurate machine learning (ML)-based model remains unavailable. The aim of this study was to develop and validate a ML-based prognostic model to predict survival in patients with cirrhosis after TIPS placement.

METHODS

In this retrospective study in China, patients diagnosed with cirrhosis after TIPS placement from 2014 to 2020 in our cohort were included to develop a ML-based model. Patients from the other two tertiary hospitals between 2016 and 2022 were as external validation cohort. The random forest (RF) model was built using 7 selected features via the least absolute shrinkage and selection operator (LASSO) regression, and subsequent 10-fold cross-validation was performed.

FINDINGS

A total of 400 patients in our cohort were included (median age and interquartile range, 59 (50, 66); 240 men). Two hundred and eighty patients made up the training set and 120 were in the testing set, and 346 patients were included in the external validation cohort. Seven attributes were selected: Na, ammonia (Amm), total bilirubin (Tb), albumin (Alb), age, creatinine (Cr), and ascites. These parameters were included in a new score named the RF model. The accuracy, precision, recall, and F1 Score of the RF model were 0.84 (95% CI: 0.76, 0.91), 0.84 (95% CI: 0.77, 0.91), 0.99 (95% CI: 0.95, 1.00), 0.91 (95% CI: 0.81, 0.10) in the testing set, and 0.88 (95% CI: 0.84, 0.91), 0.89 (95% CI: 0.85, 0.92), 0.99 (95% CI: 0.97, 1.00), 0.93 (95% CI: 0.85, 0.97) in the validation cohort, respectively. The calibration curve showed a slope of 0.875 in the testing set and a slope of 0.778 in the external validation cohort, suggesting well calibration performance. The RF model outperformed other scoring systems, such as the (Child-Turcotte-Pugh score) CTP, (model for end-stage liver disease) MELD, (sodium MELD) MELD-Na, (Freiburg index of post-TIPS survival) FIPS and (Albumin-Bilirubin) ALBI, showing the highest (area under the curve) AUC of 0.82 (95% CI: 0.72, 0.91) and 0.7 (95% CI: 0.60, 0.79) in predicting 1-year survival across the testing set and external validation cohort.

INTERPRETATION

This study developed a RF model that better predicted 1-year survival for patients with cirrhosis after TIPS placement than the other scores.

FUNDING

National Natural Science Foundation of China (grant numbers 81900552 and 82370628).

摘要

背景

多年来,尽管已经为经颈静脉肝内门体分流术(TIPS)置入术后的肝硬化患者开发了许多预后评分系统,但基于机器学习(ML)的准确模型仍然不可用。本研究的目的是开发并验证一种基于ML的预后模型,以预测TIPS置入术后肝硬化患者的生存率。

方法

在这项中国的回顾性研究中,纳入了2014年至2020年在我们队列中诊断为TIPS置入术后肝硬化的患者,以开发基于ML的模型。将另外两家三级医院2016年至2022年的患者作为外部验证队列。通过最小绝对收缩和选择算子(LASSO)回归,使用7个选定特征构建随机森林(RF)模型,并随后进行10倍交叉验证。

结果

我们队列中总共纳入了400例患者(中位年龄和四分位间距,59(50,66);240例男性)。280例患者组成训练集,120例在测试集,346例患者纳入外部验证队列。选择了7个属性:钠、氨(Amm)、总胆红素(Tb)、白蛋白(Alb)、年龄、肌酐(Cr)和腹水。这些参数被纳入一个名为RF模型的新评分中。RF模型在测试集的准确率、精确率、召回率和F1分数分别为0.84(95%CI:0.76,0.91)、0.84(95%CI:0.77,0.91)、0.99(95%CI:0.95,1.00)、0.91(95%CI:0.81,0.10),在验证队列中分别为0.88(95%CI:0.84,0.91)、0.89(95%CI:0.85,0.92)、0.99(95%CI:0.97,1.00)、0.93(95%CI:0.85,0.97)。校准曲线在测试集的斜率为0.875,在外部验证队列的斜率为0.778,表明校准性能良好。RF模型优于其他评分系统,如(Child-Turcotte-Pugh评分)CTP、(终末期肝病模型)MELD、(钠MELD)MELD-Na、(TIPS术后生存的弗莱堡指数)FIPS和(白蛋白-胆红素)ALBI,在预测测试集和外部验证队列的1年生存率时,显示出最高的曲线下面积(AUC),分别为0.82(95%CI:0.72,0.91)和0.7(95%CI:0.60,0.79)。

解读

本研究开发的RF模型在预测TIPS置入术后肝硬化患者的1年生存率方面比其他评分系统表现更好。

资助

中国国家自然科学基金(批准号81900552和82370628)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/2d552ddce762/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/a6a1ed67b7f5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/92302695d8e0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/01caa54418e2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/25159deca86a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/ed968b48d5ea/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/2d552ddce762/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/a6a1ed67b7f5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/92302695d8e0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/01caa54418e2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/25159deca86a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/ed968b48d5ea/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a31/11719861/2d552ddce762/gr6.jpg

相似文献

1
Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shunt.基于机器学习的经颈静脉肝内门体分流术后肝硬化患者生存预测模型的开发与验证
EClinicalMedicine. 2024 Dec 16;79:103001. doi: 10.1016/j.eclinm.2024.103001. eCollection 2025 Jan.
2
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.使用新型弗赖堡经颈静脉肝内门体分流术后生存指数优化经颈静脉肝内门体分流术后生存预测。
J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26.
3
FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.经颈静脉肝内门体分流术(TIPS)后生存预测的 FIPS 评分:在中国肝硬化患者队列中的外部验证及与传统风险评分的比较。
AJR Am J Roentgenol. 2022 Aug;219(2):255-267. doi: 10.2214/AJR.21.27301. Epub 2022 Feb 9.
4
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.肝硬化腹水患者血清标志物与经颈静脉肝内门体分流术预后的相关性
World J Gastrointest Surg. 2024 Feb 27;16(2):481-490. doi: 10.4240/wjgs.v16.i2.481.
5
External validation of the modified CTP score based on ammonia to predict survival in patients with cirrhosis after TIPS placement.基于血氨的改良 CTP 评分对 TIPS 术后肝硬化患者生存的外部验证。
Sci Rep. 2024 Jun 16;14(1):13886. doi: 10.1038/s41598-024-64793-z.
6
Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.基于贝叶斯网络的门静脉高压症经颈静脉肝内门体分流术后患者生存预测模型
World J Gastroenterol. 2024 Apr 7;30(13):1859-1870. doi: 10.3748/wjg.v30.i13.1859.
7
Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.验证 Freiburg 经颈静脉肝内门体分流术生存评分和经典评分在中国人行经颈静脉肝内门体分流术患者中的预后价值。
Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1074-1080. doi: 10.1097/MEG.0000000000002427. Epub 2022 Aug 24.
8
Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.白蛋白-胆红素分级与 MELD 评分预测经颈静脉肝内门体分流术(TIPS)创建后的生存情况。
Diagn Interv Imaging. 2018 Mar;99(3):163-168. doi: 10.1016/j.diii.2017.10.008. Epub 2017 Nov 16.
9
Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysis.经 TIPS 置入术治疗的患者生存预后评分系统预测准确性的比较:系统评价和荟萃分析。
Acad Radiol. 2024 Sep;31(9):3688-3710. doi: 10.1016/j.acra.2023.10.050. Epub 2023 Nov 23.
10
Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.基于内脏脂肪组织 CT 放射组学特征预测经颈静脉肝内门体分流术后肝性脑病。
Acad Radiol. 2024 May;31(5):1849-1861. doi: 10.1016/j.acra.2023.10.013. Epub 2023 Nov 24.

引用本文的文献

1
The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region.偏头痛的全球负担:按年龄、性别、国家和地区进行的30年趋势回顾与未来预测
Pain Ther. 2025 Feb;14(1):297-315. doi: 10.1007/s40122-024-00690-7. Epub 2024 Dec 11.

本文引用的文献

1
The evolution of the TIPS placement technique and its applications over four decades.经皮经肝门静脉穿刺分流术(TIPS)技术的演变及其在四十多年中的应用。
Dig Liver Dis. 2024 Dec;56(12):1980-1988. doi: 10.1016/j.dld.2024.05.018. Epub 2024 Jun 8.
2
Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients.氨与肝相关并发症相关,并可预测慢加急性肝衰竭患者的死亡率。
Sci Rep. 2024 Mar 9;14(1):5796. doi: 10.1038/s41598-024-56401-x.
3
Possible pathogenetic role of ammonia in liver cirrhosis without hyperammonemia of venous blood: The so-called latency period of abnormal ammonia metabolism.
无静脉血高氨血症的肝硬化中氨可能的致病作用:所谓氨代谢异常的潜伏期。
Hepatol Res. 2024 Mar;54(3):235-243. doi: 10.1111/hepr.14022. Epub 2024 Feb 7.
4
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.开发和验证 AMMON-OHE 模型,以预测肝硬化门诊患者显性肝性脑病发生的风险。
J Hepatol. 2023 Oct;79(4):967-976. doi: 10.1016/j.jhep.2023.05.022. Epub 2023 Jun 3.
5
A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis.基于血氨的改良 Child-Turcotte-Pugh 评分可预测失代偿期肝硬化患者的生存率。
QJM. 2023 Jun 8;116(6):436-442. doi: 10.1093/qjmed/hcad076.
6
Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.肝硬化和门静脉高压症:我们如何处理腹水及其后果。
Med Clin North Am. 2023 May;107(3):505-516. doi: 10.1016/j.mcna.2022.12.004. Epub 2023 Feb 20.
7
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis.血浆氨水平可预测肝硬化临床稳定门诊患者的肝相关并发症和死亡率。
J Hepatol. 2022 Dec;77(6):1554-1563. doi: 10.1016/j.jhep.2022.07.014. Epub 2022 Jul 22.
8
Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends.肝硬化患者的血清氨:高氨血症的临床影响、检测的实用性及全国检测趋势。
Clin Ther. 2022 Mar;44(3):e45-e57. doi: 10.1016/j.clinthera.2022.01.008. Epub 2022 Feb 4.
9
The rise and fall and rise again of ammonia as a therapeutic target in HE.氨作为肝性脑病治疗靶点的兴衰与复兴
Hepatology. 2022 May;75(5):1078-1080. doi: 10.1002/hep.32319. Epub 2022 Jan 22.
10
Liver cirrhosis.肝硬化。
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.